{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:58:56Z","timestamp":1784746736382,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s40264-018-0648-0","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T10:16:33Z","timestamp":1519985793000},"page":"697-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients"],"prefix":"10.1007","volume":"41","author":[{"name":"on behalf of IMI Web-RADR Work Package 3b Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-2434","authenticated-orcid":false,"given":"Sieta T.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Denig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Lasheras Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Hou\u00ffez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G. M.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"issue":"12","key":"648_CR1","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1517\/14740338.2015.1096342","volume":"14","author":"R Ghosh","year":"2015","unstructured":"Ghosh R, Lewis D. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media. Expert Opin Drug Saf. 2015;14(12):1845\u201353.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"648_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40264-016-0494-x","volume":"40","author":"ST Vries de","year":"2017","unstructured":"de Vries ST, Wong L, Sutcliffe A, Houyez F, Ruiz CL, Mol PG, et al. Factors influencing the use of a mobile app for reporting adverse drug reactions and receiving safety information: a qualitative study. Drug Saf. 2017;40(5):443\u201355.","journal-title":"Drug Saf"},{"issue":"3","key":"648_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2307\/30036540","volume":"27","author":"V Venkatesh","year":"2003","unstructured":"Venkatesh V, Morris MG, Gordon B, Davis FD. User acceptance of information technology: toward a unified view. MIS Q. 2003;27(3):425\u201378.","journal-title":"MIS Q"},{"key":"648_CR4","doi-asserted-by":"publisher","unstructured":"Ali EE, Leow JL, Chew L, Yap KY. Patients\u2019 perception of app-based educational and behavioural interventions for enhancing oral anticancer medication adherence. J Cancer Educ. \n                    https:\/\/doi.org\/10.1007\/s13187-017-1248-x\n                    \n                   (Epub 2017 Jul 14).","DOI":"10.1007\/s13187-017-1248-x"},{"issue":"7","key":"648_CR5","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.2196\/mhealth.7853","volume":"5","author":"RJ Lucero","year":"2017","unstructured":"Lucero RJ, Frimpong JA, Fehlberg EA, Bjarnadottir RI, Weaver MT, Cook C, et al. The relationship between individual characteristics and interest in using a mobile phone app for HIV self-management: observational cohort study of people living with HIV. JMIR Mhealth Uhealth. 2017;5(7):e100.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"4","key":"648_CR6","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.2196\/mhealth.3710","volume":"2","author":"MS Bender","year":"2014","unstructured":"Bender MS, Choi J, Arai S, Paul SM, Gonzalez P, Fukuoka Y. Digital technology ownership, usage, and factors predicting downloading health apps among Caucasian, Filipino, Korean, and Latino Americans: the digital link to health survey. JMIR Mhealth Uhealth. 2014;2(4):e43.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"4","key":"648_CR7","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.2196\/jmir.5604","volume":"19","author":"JK Carroll","year":"2017","unstructured":"Carroll JK, Moorhead A, Bond R, LeBlanc WG, Petrella RJ, Fiscella K. Who uses mobile phone health apps and does use matter? A secondary data analytics approach. J Med Internet Res. 2017;19(4):e125.","journal-title":"J Med Internet Res"},{"issue":"4","key":"648_CR8","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.2196\/mhealth.4924","volume":"3","author":"P Krebs","year":"2015","unstructured":"Krebs P, Duncan DT. Health app use among US mobile phone owners: a national survey. JMIR Mhealth Uhealth. 2015;3(4):e101.","journal-title":"JMIR Mhealth Uhealth"},{"key":"648_CR9","doi-asserted-by":"publisher","unstructured":"Montastruc F, Bagheri H, Lacroix I, Damase-Michel C, Chebane L, Rousseau V, et al. Adverse drug reaction reports received through the mobile app, VigiBIP\u00ae: a comparison with classical methods of reporting. Drug Saf. \n                    https:\/\/doi.org\/10.1007\/s40264-017-0630-2\n                    \n                   (Epub 2017 Dec 21).","DOI":"10.1007\/s40264-017-0630-2"},{"issue":"1","key":"648_CR10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1536867X0600600104","volume":"6","author":"R Williams","year":"2006","unstructured":"Williams R. Generalized ordered logit\/partial proportional odds models for ordinal dependent variables. Stata J. 2006;6(1):58\u201382.","journal-title":"Stata J"},{"issue":"1","key":"648_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0022250X.2015.1112384","volume":"40","author":"R Williams","year":"2016","unstructured":"Williams R. Understanding and interpreting generalized ordered logit models. J Math Sociol. 2016;40(1):7\u201320.","journal-title":"J Math Sociol"},{"issue":"6","key":"648_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2125.2005.02504.x","volume":"60","author":"A Vallano","year":"2005","unstructured":"Vallano A, Cereza G, Pedros C, Agusti A, Danes I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"648_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19\u201331.","journal-title":"Drug Saf"},{"issue":"2","key":"648_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jonm.12310","volume":"24","author":"A Angelis De","year":"2016","unstructured":"De Angelis A, Colaceci S, Giusti A, Vellone E, Alvaro R. Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review. J Nurs Manag. 2016;24(2):151\u201363.","journal-title":"J Nurs Manag"},{"issue":"4","key":"648_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bcp.13159","volume":"83","author":"R Al Dweik","year":"2017","unstructured":"Al Dweik R, Stacey D, Kohen D, Yaya S. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875\u201383.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"648_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/BF03261992","volume":"35","author":"S Piening","year":"2012","unstructured":"Piening S, Haaijer-Ruskamp FM, de Graeff PA, Straus SM, Mol PG. Healthcare professionals\u2019 self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands. Drug Saf. 2012;35(11):1061\u201372.","journal-title":"Drug Saf"},{"issue":"12","key":"648_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00005650-200212000-00004","volume":"40","author":"PA Glassman","year":"2002","unstructured":"Glassman PA, Simon B, Belperio P, Lanto A. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care. 2002;40(12):1161\u201371.","journal-title":"Med Care"},{"issue":"5","key":"648_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00228-014-1653-6","volume":"70","author":"N Chaipichit","year":"2014","unstructured":"Chaipichit N, Krska J, Pratipanawatr T, Uchaipichat V, Jarernsiripornkul N. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Eur J Clin Pharmacol. 2014;70(5):607\u201315.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"648_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40264-013-0036-8","volume":"36","author":"ST Vries de","year":"2013","unstructured":"de Vries ST, Mol PG, de Zeeuw D, Haaijer-Ruskamp FM, Denig P. Development and initial validation of a patient-reported adverse drug event questionnaire. Drug Saf. 2013;36(9):765\u201377.","journal-title":"Drug Saf"},{"issue":"9","key":"648_CR20","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s11136-014-0715-7","volume":"23","author":"ST Vries de","year":"2014","unstructured":"de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. The validity of a patient-reported adverse drug event questionnaire using different recall periods. Qual Life Res. 2014;23(9):2439\u201345.","journal-title":"Qual Life Res"},{"issue":"6","key":"648_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2125.2009.03421.x","volume":"67","author":"N Britten","year":"2009","unstructured":"Britten N. Medication errors: the role of the patient. Br J Clin Pharmacol. 2009;67(6):646\u201350.","journal-title":"Br J Clin Pharmacol"},{"key":"648_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12955-014-0103-6","volume":"12","author":"ST Vries de","year":"2014","unstructured":"de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study. Health Qual Life Outcomes. 2014;12:103.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"648_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/archinte.165.2.234","volume":"165","author":"SN Weingart","year":"2005","unstructured":"Weingart SN, Gandhi TK, Seger AC, Seger DL, Borus J, Burdick E, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165(2):234\u201340.","journal-title":"Arch Intern Med"},{"key":"648_CR24","unstructured":"Tellis GJ, Chandrasekaran D. Does culture matter? Assessing response biases in cross-national survey research. Int J Res Mark 2010. \n                    https:\/\/ssrn.com\/abstract=1659911\n                    \n                  . Accessed 30 Jan 2018."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-018-0648-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T19:48:29Z","timestamp":1551469709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-018-0648-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s40264-018-0648-0","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"2 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study protocol was submitted to (a member of) an ethics committee in The UK, The Netherlands and Germany. In The UK, approval was obtained from the UCL Research Ethics Committee (Project ID number 6855\/001). In The Netherlands, the Medical Ethics Committee of the University Medical Center Groningen (METc UMCG) determined that ethical approval was not needed for this study (reference number M16.191043). In Germany, a review by an ethics committee was not necessary. Therefore, no further approval was deemed necessary for the other countries. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Web-RADR project has received support from the Innovative Medicine Initiative Joint Undertaking () under Grant Agreement n\u25e6 115632, resources of which are composed of financial contribution from the European Union\u2019s Seventh Framework Programme FP7\/2007-2013 and EFPIA companies\u2019 in kind contribution, , UK.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Sieta T. de Vries, Petra Denig, Carmen Lasheras Ruiz, Fran\u00e7ois Hou\u00ffez, Lisa Wong, and Alastair Sutcliffe have no conflicts of interest that are directly relevant to the content of this study. Peter G. M. Mol is an employee of the Dutch Medicines Evaluation Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}